SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Panacos Pharmaceuticals (PANC) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (18)12/19/2006 5:01:00 PM
From: dr.praveen  Read Replies (1) | Respond to of 53
 
Hi Tuck...They wanted to try higher doses than 600mg if these results show a good safety profile with dose dependant efficacy. But with 25% bioavailability I don't think FDA will allow them. So inorder to get 360mg dose which is the highest dose they are testing now, with 25% oral bioavailability, they have to give 1440mg tablet which is impractical.

Let's see what they'll say on the c/c


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News